Thymic stromal-derived lymphopoietin (TSLP), the ligand binding to CRLF2, induces leukemia proliferation involving mTOR signaling [7] and cases of Ph-like ALL with aberrant CRLF2 expression displayed increased mTOR signaling activity [8, 23]. Here, CRLF2 is linked to leukemia.